8.91 USD
↗ 0.03 (0.34%)AT CLOSE (11:59 AM EDT)
Climb Bio, Inc. Common Stock
CLYMNASDAQ • USD
8.98
↗ 0.07 (0.73%)
POST MARKET (AS OF 06:19 PM EDT)
Post Market
AS OF 06:19 PM EDT
8.98
↗ 0.07 (0.73%)
Market: CLOSED
Open?$8.89
High?$9.10
Low?$7.91
Prev. Close?$8.88
Volume?1.8M
Avg. Volume?688.1K
VWAP?$8.59
Rel. Volume?2.60x
Bid / Ask
Bid?$8.22 × 100
Ask?$9.40 × 1.0K
Spread?$1.18
Midpoint?$8.81
Valuation & Ratios
Market Cap?425.6M
Shares Out?47.8M
Float?32.0M
Float %?67.1%
P/E Ratio?N/A
P/B Ratio?2.65
EPS?-$1.25
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.
Themes
Employees
29
Market Cap
424.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-08-10
Address
20 WILLIAM STREET
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
WELLESLEY HILLS, MA 02481
Phone: 1-866-857-2596
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.16Strong
Quick Ratio?15.16Strong
Cash Ratio?5.11Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.65CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.8CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-37.3%WEAK▾
ROA?-35.7%WEAK▾
Cash Flow & Enterprise
FCF?$-54542000
Enterprise Value?$389.9M
Fundamentals ratios updated end of day